Market Closed - Swiss Exchange 11:30:41 2024-05-31 am EDT 5-day change 1st Jan Change
80.34 CHF +0.17% Intraday chart for Alcon Inc. -2.05% +22.39%

Business Summary

Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows:

- ophthalmic surgical products and equipment (56.7%): consumables (51.2% of net sales), implantable products (32%) and other products (16.8%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors;

- vision care products (43.3%): contact lenses (59.2% of sales) and eye care products (40.8%; eye drops and ophthalmic ointments, etc.)

At the end of 2023, the group operated 19 production sites worldwide.

Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (46%), Japan (6.2%), China (5.6%) and other (41,5%).

Number of employees: 25,000

Sales per Business

CHF in Million2022Weight2023Weight Delta
Surgical
56.7 %
4,818 58.3 % 4,775 56.7 % -0.89%
Vision Care
43.3 %
3,447 41.7 % 3,645 43.3 % +5.75%

Sales per region

CHF in Million2022Weight2023Weight Delta
United States
46.0 %
3,722 45.0 % 3,875 46.0 % +4.11%
Other
41.5 %
3,492 42.2 % 3,491 41.5 % -0.01%
Japan
6.2 %
542 6.6 % 524 6.2 % -3.42%
China
5.6 %
453 5.5 % 473 5.6 % +4.42%
Switzerland
0.7 %
56 0.7 % 58 0.7 % +2.07%

Managers

Managers TitleAgeSince
Chief Executive Officer 58 16-06-30
Director of Finance/CFO 56 19-04-07
Chief Tech/Sci/R&D Officer - 11-05-31
Chief Tech/Sci/R&D Officer 65 18-07-31
Chief Tech/Sci/R&D Officer 63 91-03-31
Investor Relations Contact - -
Corporate Officer/Principal - 17-05-31
Human Resources Officer - 20-03-31
Corporate Officer/Principal 56 94-02-28
Corporate Officer/Principal 57 11-12-31

Members of the board

Members of the board TitleAgeSince
Chairman 68 18-06-30
Director/Board Member 65 18-12-31
Director/Board Member 60 19-01-31
Director/Board Member 63 19-03-31
Director/Board Member 65 18-12-31
Director/Board Member 63 18-12-31
Director/Board Member 56 18-12-31
Director/Board Member 56 18-12-31
Director/Board Member 61 18-12-31
Director/Board Member 67 22-04-26

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 499,700,000 492,617,084 ( 98.58 %) 5,300,000 ( 1.061 %) 98.58 %

Shareholders

NameEquities%Valuation
Vanguard Fiduciary Trust Co.
3.751 %
18,744,108 3.751 % 1 478 M CHF
Credit Suisse International
3.093 %
15,456,411 3.093 % 1 219 M CHF
Aristotle Capital Management LLC
2.641 %
13,195,446 2.641 % 1 040 M CHF
Norges Bank (13F)
2.524 %
12,611,176 2.524 % 994 M CHF
ClearBridge Investments LLC
1.898 %
9,483,164 1.898 % 748 M CHF
Harding Loevner LP
1.680 %
8,393,242 1.680 % 662 M CHF
Zürcher Kantonalbank (Investment Management)
1.636 %
8,174,537 1.636 % 644 M CHF
Barclays Bank Plc
1.617 %
8,078,281 1.617 % 637 M CHF
AKO Capital LLP
1.300 %
6,496,157 1.300 % 512 M CHF
6,438,707 1.289 % 508 M CHF
NameEquities%Valuation
Western Asset Management Company DTVM Ltda.
0.0117 %
582,869 0.0117 % 5 M CHF

Holdings

NameEquities%Valuation
6,438,707 1.29% 507,627,660 $

Company contact information

Alcon AG

Royce Bedward Chemin de Blandonnet 8

1214, Geneva

+41 589 112 110

http://www.alcon.com
address Alcon Inc.(ALC)

Group companies

NameCategory and Sector
Medical Distributors
Alcon Management SA
Finance/Rental/Leasing
Pharmaceuticals: Major
Medical Specialties
Pharmaceuticals: Major